Structure Therapeutics details positive trial data for a weight-loss pill, and the stock rockets

nileshsha@hotmail.com
Structure Therapeutics details positive trial data for a weight-loss pill, and the stock rockets



Structure Therapeutics details positive trial data for a weight-loss pill, and the stock rockets
Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron, that just showed positive results from a Phase 2 trial.


www.marketwatch.com
#Structure #Therapeutics #details #positive #trial #data #weightloss #pill #stock #rockets

Related reading:
Share: X · Facebook · LinkedIn

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *